Circadian variation of malignant ventricular arrhythmias in patients with ischemic and nonischemic heart disease after cardioverter defibrillator implantation

Journal of the American College of Cardiology

Volumn 34, Issue 5, 1999, Pages 1560-1568

  Englund, Anders ^a,b   Behrens, Steffen ^b,c   Wegscheider, Karl ^c,d   Rowland, Edward ^d  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

^d UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SOTALOL;

ADULT; AGED; ARTICLE; CIRCADIAN RHYTHM; DEFIBRILLATOR; DRUG EFFICACY; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SUDDEN DEATH;

EID: 0033230086     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00369-1     Document Type: Article

References (56)

1. Levine RL, Pepe PE, Fromm RE, Curka PA, Clark PA. Prospective evidence of a circadian rhythm for out-of-hospital cardiac arrests. JAMA 1992;267:2935-7.
2. Arntz HR, Willich SN, Oeff M, et al. Circadian variation of sudden cardiac death reflects age-related variability in ventricular fibrillation. Circulation 1993;88:2284-9.
3. Thakur RK, Hoffmann RG, Olson DW, et al. Circadian variation in sudden cardiac death: effects of age, sex, and initial cardiac rhythm. Ann Emerg Med 1996;27:29-34.
4. Hansen O, Johansson BW, Gullberg B. Circadian distribution of onset of acute myocardial infarction in subgroups from analysis of 10,791 patients treated in a single center. Am J Cardiol 1992;69:1003-8.
5. Pepine CJ. Circadian variations in myocardial ischemia. Implications for management. JAMA 1991;265:386-90.
6. Mulcahy D, Keegan J, Cunningham D, et al. Circadian variation of total ischaemic burden and its alteration with anti-anginal agents. Lancet 1988;2:755-9.
7. Lucente M, Rebuzzi AG, Lanza GA, et al. Circadian variation of ventricular tachycardia in acute myocardial infarction. Am J Cardiol 1988;62:670-4.
8. Benhorin J, Banai S, Moriel M, et al. Circadian variations in ischemic threshold and their relation to the occurrence of ischemic episodes. Circulation 1993;87:808-14.
9. Cannon CP, McCabe CH, Stone PH, et al. Circadian variation in the onset of unstable angina and non-Q-wave acute myocardial infarction (the TIMI III Registry and TIMI IIIB). Am J Cardiol 1997;79:253-8.
10. Aronow WS, Ahn C, Mercando AD, Epstein S. Effect of propranolol on circadian variation of myocardial ischemia in elderly patients with heart disease and complex ventricular arrhythmias. Am J Cardiol 1995;75:837-9.
11. Siegel D, Black DM, Seeley DG, Hulley SB. Circadian variation in ventricular arrhythmias in hypertensive men. Am J Cardiol 1992;69:344-7.
12. Muller JE, Ludmer PL, Willich SN, et al. Circadian variation in the frequency of sudden cardiac death. Circulation 1987;75:131-8.
13. Willich SN, Goldberg RJ, Maclure M, Perriello L, Muller JE. Increased onset of sudden cardiac death in the first three hours after awakening. Am J Cardiol 1992;70:65-8.
14. Behrens S, Galecka M, Bruggemann T, et al. Circadian variation of sustained ventricular tachyarrhythmias terminated by appropriate shocks in patients with an implantable cardioverter defibrillator. Am Heart J 1995;130:79-84.
15. d'Avila A, Wellens F, Andries E, Brugada P. At what time are implantable defibrillator shocks delivered? Evidence for individual circadian variance in sudden cardiac death? Eur Heart J 1995;16:1231-3.
16. Mallavarapu C, Pancholy S, Schwartzman D, et al. Circadian variation of ventricular arrhythmia recurrences after cardioverter-defibrillator implantation in patients with healed myocardial infarcts. Am J Cardiol 1995;75:1140-4.
17. Wood MA, Simpson PM, London WB, et al. Circadian pattern of ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators. J Am Coll Cardiol 1995;25:901-7.
18. Lampert R, Rosenfeld L, Batsford W, Lee F, McPherson C. Circadian variation of sustained ventricular tachycardia in patients with coronary artery disease and implantable cardioverter-defibrillators. Circulation 1994;90:241-7.
19. Rosenqvist M, Beyer T, den Dulk K, Minten J, Lindemans F, on the behalf of the European 7219 Jewel ICD investigators. Adverse events with transvenous implantable cardioverter defibrillators. A prospective multicenter study. Circulation 1998;98:663-70.
20. Spielberg C, Falkenhahn D, Willich SN, Wegscheider K, Völler H. Circadian, day-of-week, and seasonal variability in myocardial infarction: comparison between working and retired patients. Am Heart J 1996;132:579-85.
21. Röhmel J, Streitberg B, Tismer C. A permutation approach to configural frequency analysis (CFA) and the iterated hypergeometric distribution. In: Dirschedl P, Ostermann R, eds. Computational Statistics. Berlin, Germany: Physica, 1994:355-78.
22. Krauth J, Lienert G. Nichtparametrischer Nachweis von Syndromen durch simultane Binomialtests. Biometrische Zeitung 1973;15:13-20.
23. Lehmacher W. A more powerful simultaneous test procedure in configural frequency analysis. Biomet J 1981;23:429-36.
24. Perli HG, Hommel G, Lehmacher W. Test procedures in configural frequency analysis (CFA)-controlling the local and multiple level. Biomet J 1987;29:255-67.
25. Agresti A. Categorical Data Analysis. New York: Wiley, 1990.
26. Detry JM, Vincent M. Circadian rhythms in cardiovascular disease: the crucial hours. J Hum Hypertens 1992;6:S3-8.
27. Hohnloser SH, Klingenheben T. Insights into the pathogenesis of sudden cardiac death from analysis of circadian fluctuations of potential triggering factors. PACE 1994;17:428-33.
28. Willich SN, Maclure M, Mittleman M, Arntz HR, Muller JE. Sudden cardiac death. Support for a role of triggering in causation. Circulation 1993;87:1442-50.
29. Huikuri HV, Yli-Mayry S, Linnaluoto MK, Ikaheimo MJ. Diurnal fluctuations in human ventricular and atrial refractoriness. PACE 1995;18:1362-8.
30. Klingenheben T, Rapp U, Hohnloser SH. Circadian variation of heart rate variability in postinfarction patients with and without lifethreatening ventricular tachyarrhythmias. J Cardiovasc Electrophysiol 1995;6:357-64.
31. Nakagawa M, Saikawa T, Ito M. Progressive reduction of heart rate variability with eventual sudden death in two patients. Br Heart J 1994;71:87-8.
32. Lampe F, Bruggemann T, Ehlers C, et al. Factors triggering appropriate shock episodes in patients with an implantable cardioverter defibrillator (abstr). Eur Heart J 1997;18:P651.
33. Behrens S, Ehlers C, Bruggemann T, et al. Modification of the circadian pattern of ventricular tachyarrhythmias by beta blocker therapy. Clin Cardiol 1997;20:253-7.
34. Peters RW, Muller JE, Goldstein S, Byington R, Friedman LM. Propranolol and the morning increase in the frequency of sudden cardiac death (BHAT study). Am J Cardiol 1989;63:1518-20.
35. Kupari M, Koskinen P, Leinonen H. Double-peaking circadian variation in the occurrence of sustained supraventricular tachyarrhythmias. Am Heart J 1990;120:1364-9.
36. Muller JE, Stone PH, Turi ZG, et al. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 1985;313:1315-22.
37. Peters RW, Mitchell LB, Brooks MM, et al. Circadian pattern of arrhythmic death in patients receiving encainide, flecainide or moncizine in the Cardiac Arrhythmia Suppression Trial (CAST). J Am Coll Cardiol 1994;23:283-9.
38. Linsell CR, Lightman SL, Mullen PE, Brown MJ, Causon RC. Circadian rhythm of epinephrine and norepinephrine in man. J Clin Endocrinol Metab 1985;60:1210-5.
39. Pietrucha A, Matysek J, Piwowarska W, et al. Analysis of circadian distribution of premature ventricular contractions in patients after heart transplantation. PACE 1994;17:2064-7.
40. Cinca J, Moya A, Figueras J, Roma F, Rius J. Circadian variations in the electrical properties of the human heart assessed by sequential bedside electrophysiologic testing. Am Heart J 1986;112:315-21.
41. Kong TQ_Jr, Goldberger JJ, Parker M, Wang T, Kadish AH. Circadian variation in human ventricular refractoriness. Circulation 1995;92:1507-16.
42. Molnar J, Zhang F, Weiss J, Ehlert FA, Rosenthal JE. Diurnal pattern of QTc interval. How long is prolonged? Possible relation to circadian triggers of cardiovascular events. J Am Coll Cardiol 1996;27:76-83.
43. Behar S, Halabi M, Reicher-Reiss H, et al. Circadian variation and possible external triggers of onset of myocardial infarction. SPRINT Study Group. Am J Med 1993;94:395-400.
44. Hausmann D, Lichtlen PR, Nikutta P, Wenzlaff P, Daniel WG. Circadian variation of myocardial ischemia in patients with stable coronary artery disease. Chronobiol Int 1991;8:385-98.
45. Behar S, Reicher-Reiss H, Goldbourt U, Kaplinsky E. Circadian variation in pain onset in unstable angina pectoris. Am J Cardiol 1991;67:91-3.
46. Hausmann D, Nikutta P, Trappe HJ, Daniel WG, Wenzlaff P, Lichtlen PR. Circadian distribution of the characteristics of ischemic episodes in patients with stable coronary artery disease. Am J Cardiol 1990;66:668-72.
47. Argentino C, Toni D, Rasura M, et al. Circadian variation in the frequency of ischemic stroke. Stroke 1990;21:387-9.
48. Wroe SJ, Sandercock P, Bamford J, Dennis M, Slattery J, Warlow C. Diurnal variation in incidence of stroke: oxfordshire community stroke project. BMJ 1992;304:155-7.
49. el-Tamimi H, Mansour M, Pepine CJ, Wargovich TJ, Chen H. Circadian variation in coronary tone in patients with stable angina. Protective role of the endothelium. Circulation 1995;92:3201-5.
50. Kurnik PB. Circadian variation in the efficacy of tissue-type plasminogen activator. Circulation 1995;91:1341-6.
51. Bridges AB, McLaren M, Scott NA, Pringle TH, McNeill GP, Belch JJ. Circadian variation of tissue plasminogen activator and its inhibitor, von Willebrand factor antigen, and prostacyclin stimulating factor in men with ischaemic heart disease. Br Heart J 1993;69:121-4.
52. Angleton P, Chandler WL, Schmer G. Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1). Circulation 1989;79:101-6.
53. Sakata K, Hoshino T, Yoshida H, et al. Circadian fluctuations of tissue plasminogen activator antigen and plasminogen activator inhibitor-1 antigens in vasospastic angina. Am Heart J 1992;124:854-60.
54. Ogawa H, Yasue H, Oshima S, Okumura K, Matsuyama K, Obata K. Circadian variation of plasma fibrinopeptide A level in patients with variant angina. Circulation 1989;80:1617-26.
55. Wit AL, Janse JJ. Experimental models of ventricular tachycardia and ventricular fibrillation caused by ischemia and infarction. Circulation 1992;85:32-42.
56. Lambert CR, Raymenants E, Pepine CJ. Time-series analysis of long-term ambulatory myocardial ischemia: effects of beta-adrenergic and calcium channel blockade. Am Heart J 1995;129:677-84.